Richard M Allen1, Linda A Dykstra, Regina M Carelli. 1. Department of Psychology, University of Colorado at Denver and Health Sciences Center, Downtown Denver Campus, CB# 173, P.O. Box 173364, Denver, CO 80217, USA. richard.allen@cudenver.edu
Abstract
RATIONALE: Chronic high dose consumption of cocaine is associated with significant negative effects to individual users and society. Nevertheless, the precise mechanisms that mediate increases in cocaine consumption in a drug-using individual are not fully understood. OBJECTIVES: This study used a long access version of the drug self-administration procedure to determine whether escalation of cocaine consumption is mediated by increased activity through N-methyl-D: -aspartate (NMDA) receptors. MATERIALS AND METHODS: Male Sprague-Dawley rats (n = 63) were first trained to self-administer cocaine (0.33 mg/infusion, i.v.) under a fixed-ratio 1 schedule of reinforcement. After training, some rats were implanted with subcutaneous osmotic minipumps filled with vehicle or the competitive NMDA receptor antagonist, LY235959, and subsequently allowed to self-administer cocaine in short (2 h) or long (6 h) access self-administration sessions. RESULTS: Vehicle-treated rats escalated cocaine self-administration across 14 long-access self-administration sessions. Rats treated with LY235959 via osmotic minipump, but not twice daily injections, escalated cocaine self-administration at a greater rate and to a greater degree than vehicle-treated rats. In post-escalation cocaine dose-infusion tests, rats treated continuously with LY235959 self-administered more cocaine (0.08-1.32 mg/infusion) than vehicle-treated rats, regardless of access condition, shifting the dose-infusion curves upward. During extinction sessions, which were conducted after the escalation phase of the study, rats that had long (6 h) access to cocaine stopped responding sooner than rats that had short (2 h) access to cocaine, independent of LY235959 treatment. CONCLUSIONS: These data are consistent with hypo-glutamatergic consequences of repeated cocaine exposure.
RATIONALE: Chronic high dose consumption of cocaine is associated with significant negative effects to individual users and society. Nevertheless, the precise mechanisms that mediate increases in cocaine consumption in a drug-using individual are not fully understood. OBJECTIVES: This study used a long access version of the drug self-administration procedure to determine whether escalation of cocaine consumption is mediated by increased activity through N-methyl-D: -aspartate (NMDA) receptors. MATERIALS AND METHODS: Male Sprague-Dawley rats (n = 63) were first trained to self-administer cocaine (0.33 mg/infusion, i.v.) under a fixed-ratio 1 schedule of reinforcement. After training, some rats were implanted with subcutaneous osmotic minipumps filled with vehicle or the competitive NMDA receptor antagonist, LY235959, and subsequently allowed to self-administer cocaine in short (2 h) or long (6 h) access self-administration sessions. RESULTS: Vehicle-treated rats escalated cocaine self-administration across 14 long-access self-administration sessions. Rats treated with LY235959 via osmotic minipump, but not twice daily injections, escalated cocaine self-administration at a greater rate and to a greater degree than vehicle-treated rats. In post-escalation cocaine dose-infusion tests, rats treated continuously with LY235959 self-administered more cocaine (0.08-1.32 mg/infusion) than vehicle-treated rats, regardless of access condition, shifting the dose-infusion curves upward. During extinction sessions, which were conducted after the escalation phase of the study, rats that had long (6 h) access to cocaine stopped responding sooner than rats that had short (2 h) access to cocaine, independent of LY235959 treatment. CONCLUSIONS: These data are consistent with hypo-glutamatergic consequences of repeated cocaine exposure.
Authors: Richard M Allen; Regina M Carelli; Linda A Dykstra; Therese L Suchey; Carson V Everett Journal: J Pharmacol Exp Ther Date: 2005-07-15 Impact factor: 4.030
Authors: Wendy J Lynch; Matthew J Girgenti; Florence J Breslin; Samuel S Newton; Jane R Taylor Journal: Brain Res Date: 2008-03-15 Impact factor: 3.252
Authors: Wendy J Lynch; Alexis B Peterson; Victoria Sanchez; Jean Abel; Mark A Smith Journal: Neurosci Biobehav Rev Date: 2013-06-24 Impact factor: 8.989
Authors: Osnat M Ben-Shahar; Karen K Szumlinski; Kevin D Lominac; Ami Cohen; Evan Gordon; Kyle L Ploense; Jeremy DeMartini; Nicholas Bernstein; Nicole M Rudy; Ahmad N Nabhan; Arianne Sacramento; Kelly Pagano; Giovanni A Carosso; Nick Woodward Journal: Addict Biol Date: 2012-02-17 Impact factor: 4.280
Authors: Richard M Allen; Kristina A Uban; Elizabeth M Atwood; David S Albeck; Dorothy J Yamamoto Journal: Pharmacol Biochem Behav Date: 2007-07-21 Impact factor: 3.533
Authors: Kathleen M Kantak; Jamie M Gauthier; Elon Mathieson; Eudokia Knyazhanskaya; Pedro Rodriguez-Echemendia; Heng-Ye Man Journal: Behav Brain Res Date: 2020-08-02 Impact factor: 3.332